IDX SYSTEMS CORP
8-K, 2000-07-20
COMPUTER INTEGRATED SYSTEMS DESIGN
Previous: STOCKWALK COM GROUP INC, PRE 14A, 2000-07-20
Next: IDX SYSTEMS CORP, 8-K, EX-2, 2000-07-20





================================================================================

                                  UNITED STATES

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES

                              EXCHANGE ACT OF 1934



                                  July 20, 2000
                                (Date of Report)


                                  July 13, 2000
                        (Date of earliest event reported)


                            -------------------------

                         Commission File Number 0-26816

                             IDX SYSTEMS CORPORATION

             (Exact name of registrant as specified in its charter)


          Vermont                                        03-0222230
(State or other jurisdiction of                      (I.R.S. Employer
incorporation or organization)                       Identification No.)

                               1400 Shelburne Road

                           South Burlington, VT 05403

                    (Address of principal executive offices)

                  Registrant's telephone number, including area
                              code: (802-862-1022)

================================================================================

                             Exhibit Index on Page 2


<PAGE>
ITEM 5.  OTHER EVENTS

      On July 13, 2000, the Company entered into an Agreement and Plan of Merger
      ("Agreement") with Allscripts, Inc., a provider of clinical information
      systems for physicians. Under the Agreement, which is subject to
      regulatory and Allscripts' stockholder approval, Allscripts will acquire
      the Company's subsidiary Channelhealth Incorporated ("ChannelHealth"), and
      the Company and Allscripts will enter into a ten-year strategic alliance
      involving the development and marketing of their complementary products.
      The Company currently owns approximately 90% of the issued and outstanding
      Common Stock, $.001 par value per share ("ChannelHealth Shares"), of
      ChannelHealth. Prior to the closing of the acquisition of ChannelHealth,
      the Company will purchase the eCommerce Channel(TM) and portions of the
      Patient Channel(TM) businesses from ChannelHealth in consideration of the
      cancellation of a portion of the ChannelHealth Shares currently held by
      the Company, with the effect that the Company will own approximately 87.3%
      of ChannelHealth immediately before the acquisition of ChannelHealth by
      Allscripts.

      The Agreement provides for Allscripts to issue approximately 8,595,000
      shares of Common Stock, $.01 par value per share ("Allscripts Shares"), or
      21.3% of Allscripts on a pro forma fully diluted basis, of which the
      Company will receive approximately 7,500,000 Allscripts Shares, or 18.6%
      of Allscripts on a pro forma fully diluted basis. At the closing of the
      transactions contemplated by the Agreement, IDX and Allscripts will enter
      into a Stock Rights and Restrictions Agreement pursuant to which each
      party will agree to certain restrictions on its activities as a
      stockholder in the other (including with respect to the ability to
      purchase additional shares), IDX will agree to certain restrictions on its
      ability to sell, transfer or otherwise dispose of its shares in Allscripts
      and Allscripts will agree to appoint an IDX representative to its Board of
      Directors so long as certain conditions are met.

      Pursuant to the ten-year strategic alliance, Allscripts will become the
      exclusive provider of point of care clinical applications sold by IDX to
      physician practices.


ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS

(c)      Exhibits.

EXHIBIT NO.          DESCRIPTION
-----------          -----------

     2               Agreement and Plan of Merger
                     dated  as of July 13,  2000,  by and
                     among Allscripts Holding, Inc.,
                     Allscripts, Inc., Bursar Acquisition,
                     Inc., Bursar Acquisition No. 2, Inc.,
                     IDX Systems Corporation and
                     Channelhealth Incorporated

     99              IDX News Release dated July 13, 2000







                                     Page 2
<PAGE>
                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.



                                    IDX SYSTEMS CORPORATION
                                    (Registrant)

Date:  July 20, 2000                /s/ JOHN A. KANE
                                    ------------------------------------
                                    John A. Kane
                                    Vice President, Finance and Administration
                                    Chief Financial Officer, and Treasurer









                                     Page 3
<PAGE>
                                 EXHIBIT INDEX
                                 -------------

EXHIBIT NO.          DESCRIPTION
-----------          -----------

    2                Agreement and Plan of Merger
                     dated  as of July 13,  2000,  by and
                     among Allscripts Holding, Inc.,
                     Allscripts, Inc., Bursar Acquisition,
                     Inc., Bursar Acquisition No. 2, Inc.,
                     IDX Systems Corporation and
                     Channelhealth Incorporated

    99               IDX News Release dated July 13, 2000






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission